NDC 11673-540 - daytime severe cold and cough and nighttime severe cold and cough
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11673-540
- Package NDCs from labels
- 11673-540-06
- Manufacturer
- Target Corporation
- Effective date
- 2018-01-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| daytime severe cold and cough - Target Corporation | Target Corporation | 2018-01-18 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-540-06 | daytime severe cold and cough and nighttime severe cold and cough | 6 in 1 CARTON | POWDER, FOR SOLUTION | 6 | 20 mg | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11673-540 | DAYTIME SEVERE COLD AND COUGH AND NIGHTTIME SEVERE COLD AND COUGH (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) KIT [TARGET CORPORATION] | 1 | Unmatched | 20180123_62eec235-431f-4429-b173-d4a9b45a4e36.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pain Reliever | ACETAMINOPHEN | Shield Pharmaceuticals Corp | 61e50135-a7c2-4a86-8a1a-d47b41d3f9d1 | 2025-11-07 | Warnings | 362O9ITL9D |
| Allergy plus Sinus Headache | ACETAMINOPHEN 325 MG, DIPHENHYDRAMINE HCL 12.5 MG, PHENYLEPHRINE HCL 5 MG | Shield Pharmaceuticals Corp | 093649a4-f968-49bd-83af-bb7e0f448ecf | 2025-11-07 | Warnings | 04JA59TNSJ TC2D6JAD40 362O9ITL9D |
| TARGET Childrens Cold and Cough | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR | TARGET CORPORATION | bfc91c71-0506-4e94-8bfe-dc9e4bf959da | 2025-11-07 | Warnings | 9D2RTI9KYH |
| CHILDRENS COLD AND COUGH | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE | H E B | 08f4785a-c628-4e9b-9412-b2a817f9be60 | 2025-11-07 | Warnings | 9D2RTI9KYH |
| G-TUSICOF | DEXTROMETHORPHAN, GUAIFENESIN, AND PHENYLEPHRINE | Kramer Novis | d169585f-b4f4-4831-8c71-e1533ae7e7c4 | 2025-11-07 | Warnings | 9D2RTI9KYH 04JA59TNSJ |
| Cold and Flu Relief | ACETAMINOPHEN DEXTROMETHORPHAN HBR PHENYLEPHRINE HCL | QUALITY CHOICE (Chain Drug Marketing Association) | 1d512053-7a54-4691-a657-77da4c627cb8 | 2025-11-07 | Warnings | 9D2RTI9KYH 04JA59TNSJ 362O9ITL9D |
| Potassium Chloride | POTASSIUM CHLORIDE | Henry Schein, Inc. | 8367a2ae-dfd9-4515-838c-529920291ca0 | 2025-11-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Allergy and Headache | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | dc249163-26dd-42ca-b423-2f16299f2d65 | 2025-11-07 | Warnings | TC2D6JAD40 362O9ITL9D |
| Childrens Chewables | ACETAMINOPHEN | Strategic Sourcing Services LLC | af2cbbaf-9b73-440a-bc88-a790cafccc6b | 2025-11-07 | Warnings | 362O9ITL9D |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 2feda15e-f325-41fe-a442-41a8cc62b855 | 2025-11-06 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | A-S Medication Solutions | d486f982-a7d3-463d-a68d-89365ddaf5bb | 2025-11-06 | Warnings, Adverse reactions | 660YQ98I10 |
| Vicks DayQuil HIGH BLOOD PRESSURE COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | ff0bffee-9a36-8246-e053-6294a90a86c7 | 2025-11-06 | Warnings | 9D2RTI9KYH 362O9ITL9D |
| Teething-Colic | CHAMOMILLA, VALERIANA OFFICINALIS, ACONITUM NAPELLUS, APIS MELLIFICA, BAPTISIA TINCTORIA, BELLADONNA, BORAX, BRYONIA, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CHAMOMILLA, CHELIDONIUM MAJUS, COFFEA CRUDA, COLLINSONIA CANADENSIS, COLOCYNTHIS, KREOSOTUM, MAGNESIA PHOSPHORICA, NUX VOMICA, PODOPHYLLUM PELTATUM, RHEUM, SCUTELLARIA LATERIFLORA, SILICEA, TEREBINTHINA, ZINGIBER OFFICINALE | Newton Laboratories, Inc. | 9db30229-3031-ff10-e053-2995a90aff75 | 2025-11-06 | Warnings | ETJ7Z6XBU4 |
| Teething-Colic | CHAMOMILLA, VALERIANA OFFICINALIS, ACONITUM NAPELLUS, APIS MELLIFICA, BAPTISIA TINCTORIA, BELLADONNA, BORAX, BRYONIA, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CHAMOMILLA, CHELIDONIUM MAJUS, COFFEA CRUDA, COLLINSONIA CANADENSIS, COLOCYNTHIS, KREOSOTUM, MAGNESIA PHOSPHORICA, NUX VOMICA, PODOPHYLLUM PELTATUM, RHEUM, SCUTELLARIA LATERIFLORA, SILICEA, TEREBINTHINA, ZINGIBER OFFICINALE | Newton Laboratories, Inc. | 9db4790e-28c2-2dce-e053-2a95a90ae792 | 2025-11-06 | Warnings | ETJ7Z6XBU4 |
| Extra Strength Itch Relief | DIPHENHYDRAMINE HCL AND ZINC ACETATE | Chain Drug Marketing Association Inc | 1a2997bc-7741-e658-e063-6394a90af6fd | 2025-11-06 | Warnings | TC2D6JAD40 |
| Diphenhydramine HCl and Zinc Acetate | EXTRA STRENGTH ITCH RELIEF CONTINUOUS SPRAY | Topco Associates LLC | 8026c7dd-eb7b-ebea-e053-2991aa0a1b0f | 2025-11-06 | Warnings | TC2D6JAD40 |
| Diphenhydramine HCl and Zinc Acetate | EXTRA STRENGTH ITCH RELIEF | Walgreen Company | 6057b4ff-6adc-4688-893c-62d237d7d1ae | 2025-11-06 | Warnings | TC2D6JAD40 |
| ValuMeds Nasal Decongestant Phenylephrine HCl | PHENYLEPHRINE HYDROCHLORIDE | Cabinet Health P.B.C. | 21676b0c-6be2-464c-ae91-92e5f0d0087d | 2025-11-06 | Warnings | 04JA59TNSJ |
| Potassium chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 4a2173ba-556b-4ad7-be81-4da79b739490 | 2025-11-06 | Warnings, Adverse reactions | 660YQ98I10 |
| Severe Allergy Plus Sinus Headache | ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL | Wal-Mart Stores Inc | 1a1f41c4-5430-4cff-873e-6547dadc8779 | 2025-11-06 | Warnings | 04JA59TNSJ TC2D6JAD40 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.